Tobacco smoking is an important risk factor for peripheral artery disease (PAD), but it remains unknown whether smokeless tobacco, such as Swedish snuff (snus), is also associated with this disease. We used data from the Cohort of Swedish Men including 24,085 men. Individuals were grouped into never, past, and current snus dippers as well as never, past quitting >= 10 years, past, quitting < 10 years, and current smokers. Incident PAD cases were defined by linkage of the cohort with the Swedish National Patient Register. Cox proportional hazards regression was used to analyze the data. Over a mean follow-up period of 9.1 years (from July 1, 2009 to December 31, 2019), 655 incident PAD cases were ascertained. Cigarette smoking but not ...
Background: Smoking and nicotine exposure increase insulin resistance and the risk of type 2 diabete...
While smoking is a well-established risk factor for pancreatic cancer, the effect of smokeless tobac...
AbstractInterest in snus (Swedish type moist snuff) as an alternative to smoking is increasing, but ...
Tobacco smoking is an important risk factor for peripheral artery disease (PAD), but it remains unkn...
Background: Cigarette smoking is a well-known risk factor for cardiovascular disease (CVD), but whet...
Background The relationship between smoking and an increased incidence of cardiovascular diseases is...
INTRODUCTION: Cigarette smoking is a known risk factor for Type 2 diabetes, but evidence regarding f...
Previous investigations of snus use (oral moist snuff, a Swedish form of smokeless tobacco) and card...
The use of snus (also referred to as Scandinavian or Swedish moist smokeless tobacco), which is comm...
Background. Snus is a moist smokeless tobacco product with high nicotine content. Its use has a shor...
Use of snus is most prevalent in Nordic countries, and especially in Sweden, where 18% of men and 3%...
Snus is a common tobacco product in Sweden, but the cardiovascular risk profile for snus users is le...
<p>Objective Active smoking is a recognised risk factor for peripheral arterial disease (PAD)...
Snus is a smokeless tobacco product made of a moist powder of ground tobacco. It is used mainly in t...
Background: Smoking and nicotine exposure increase insulin resistance and the risk of type 2 diabete...
While smoking is a well-established risk factor for pancreatic cancer, the effect of smokeless tobac...
AbstractInterest in snus (Swedish type moist snuff) as an alternative to smoking is increasing, but ...
Tobacco smoking is an important risk factor for peripheral artery disease (PAD), but it remains unkn...
Background: Cigarette smoking is a well-known risk factor for cardiovascular disease (CVD), but whet...
Background The relationship between smoking and an increased incidence of cardiovascular diseases is...
INTRODUCTION: Cigarette smoking is a known risk factor for Type 2 diabetes, but evidence regarding f...
Previous investigations of snus use (oral moist snuff, a Swedish form of smokeless tobacco) and card...
The use of snus (also referred to as Scandinavian or Swedish moist smokeless tobacco), which is comm...
Background. Snus is a moist smokeless tobacco product with high nicotine content. Its use has a shor...
Use of snus is most prevalent in Nordic countries, and especially in Sweden, where 18% of men and 3%...
Snus is a common tobacco product in Sweden, but the cardiovascular risk profile for snus users is le...
<p>Objective Active smoking is a recognised risk factor for peripheral arterial disease (PAD)...
Snus is a smokeless tobacco product made of a moist powder of ground tobacco. It is used mainly in t...
Background: Smoking and nicotine exposure increase insulin resistance and the risk of type 2 diabete...
While smoking is a well-established risk factor for pancreatic cancer, the effect of smokeless tobac...
AbstractInterest in snus (Swedish type moist snuff) as an alternative to smoking is increasing, but ...